Larvol Delta - A-Study-to-Evaluate-the-Efficacy-and-Safety-of-Bimekizumab-in-Adult-Study-Participants-With-Active-Psoriatic-Arthritis

Bimzelx (bimekizumab-bkzx) - UCB

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

http://clinicaltrials.gov/ct2/show/NCT06624228

Jul 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next